"Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination"
In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications, particularly GLP-1 receptor agonists such as Ozempic and Wegovy
Athletes regularly deal with the natural wear and tear they place on their muscles and joints
I think healthcare prescribers need to be aware of the unintended consequences of GLP-1sbut I also think its gone too far on the [eating disorder] end where theres almost a perspective of GLP-1s are bad in almost any circumstance. The trick, he says, is to support patients in getting the care they need in the safest way possible
Andersen JV (2025) The glutamate/GABAglutamine cycle: insights, updates, and advances
Unique expression and critical role of metallothionein 3 in the control of osteoclastogenesis and osteoporosis